NEW YORK, April 30 (GenomeWeb News) - Bruker BioSciences announced at the close of market yesterday that it has closed its public offering of 17.3 million shares.
Of the shares, 3.5 million were sold by the company and 13.8 million by four stockholders related to CEO Frank Laukien. The stock was priced at $4.50 per share.
The company said last week that it hoped to raise a total of $12.6 million from the offering. The proceeds will be used for "general corporate purposes, potential acquisitions, and possibly for the repayment of debt," the company said yesterday in a statement.